Surge in Active Put Options for Sun Pharmaceutical at Rs 1,700 Strike with 3,395 Contracts
Sun Pharmaceutical Industries Ltd has become a focal point in the options market, particularly in put options, with notable trading activity. The stock has shown strong performance, outpacing its sector, while also experiencing a decline in investor participation. It remains a significant player in the pharmaceuticals and biotechnology sector.
Sun Pharmaceutical Industries Ltd has emerged as one of the most active stocks in the options market today, particularly in the put options segment. The underlying stock, SUNPHARMA, has seen significant activity with 3,395 contracts traded at a strike price of Rs 1,700, resulting in a turnover of Rs 278.53 lakhs. The open interest stands at 1,204 contracts, indicating a robust interest in this option type as it approaches its expiry date on July 31, 2025.In terms of performance, Sun Pharmaceutical has outperformed its sector by 1.21% today, with a one-day return of 2.01%. The stock has been on a positive trajectory, gaining 3.1% over the last three days. It is currently trading above its 5-day, 20-day, 50-day, and 100-day moving averages, although it remains below the 200-day moving average.
Despite this positive performance, there has been a notable decline in investor participation, with delivery volume dropping by 39.41% compared to the 5-day average. However, the stock maintains sufficient liquidity, with a trade size of Rs 5.79 crore based on 2% of the 5-day average traded value.
Overall, Sun Pharmaceutical Industries Ltd continues to attract attention in the market, reflecting its significant position within the pharmaceuticals and biotechnology industry.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
